ROYCE & ASSOCIATES LLC 13D and 13G filings for Mesa Laboratories, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-28 11:55 am Sale |
2024-12-31 | 13G | Mesa Laboratories, Inc. MLAB |
ROYCE & ASSOCIATES LLC | 287,207 5.290% |
-59,938 (-17.27%) |
Filing |
| 2024-10-15 1:29 pm Purchase |
2024-09-30 | 13G | Mesa Laboratories, Inc. MLAB |
ROYCE & ASSOCIATES LLC | 347,145 6.420% |
77,500 (+28.74%) |
Filing |
| 2024-01-23 2:18 pm Purchase |
2023-12-31 | 13G | Mesa Laboratories, Inc. MLAB |
ROYCE & ASSOCIATES LLC | 269,645 5.000% |
109,068 (+67.92%) |
Filing |
| 2023-01-27 11:03 am Sale |
2022-12-31 | 13G | Mesa Laboratories, Inc. MLAB |
ROYCE & ASSOCIATES LLC | 160,577 3.010% |
-182,161 (-53.15%) |
Filing |
| 2022-01-21 2:17 pm Purchase |
2021-12-31 | 13G | Mesa Laboratories, Inc. MLAB |
ROYCE & ASSOCIATES LLC | 342,738 6.560% |
35,544 (+11.57%) |
Filing |
| 2021-01-27 11:21 am Purchase |
2020-12-31 | 13G | Mesa Laboratories, Inc. MLAB |
ROYCE & ASSOCIATES LLC | 307,194 6.000% |
41,215 (+15.50%) |
Filing |